In vitro studies showed that azacitidine treatment in PCa DU145 cells resulted in the demethylation of DNA damage-inducible alpha (GADD45A) promoter, increasing GADD45A expression and resensitizing cells to docetaxel treatment [169]. Here, GADD45A is linked to posterior cortical atrophy.